We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

DIAGNOSTICA STAGO

Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routin... read more Featured Products: More products

Download Mobile App





Stago Diagnostics Transforms Hemostasis with Innovations at AACC 2020 Virtual Event

By LabMedica International staff writers
Posted on 17 Dec 2020
Print article
Illustration
Illustration
Diagnostica Stago (Asnières-sur-Seine, France) transformed hemostasis with its innovations on display at the all virtual 2020 AACC Annual Scientific Meeting held on December 13-17.

The company demonstrated the STA Workcell Max, a transformative specimen processing platform designed to meet the rigorous requirements of efficient hemostasis testing. With a loading capacity of 300 specimens at a time, STA Workcell Max automatically loads and balances centrifuge buckets, and prepares platelet poor plasma by centrifuging specimens using hemostasis-specific criteria. By automating front-end specimen processing, rack preparation and specimen routing, the STA Workcell Max enables allocation of skilled laboratory technologists for other more complex, value-added tasks.

Attendees of the 2020 AACC Virtual Meeting Platform viewed the company’s STA Coag Expert data management platform powering the STA Workcell Max automation line, that transforms lab QC and patient results into robust, traceable, actionable clinical insights. STA Coag Expert delivers full traceability, from operator activity to reagent and consumable lot identification for each data point. Also included, are connectivity capabilities to auto-upload QC results into a real-time peer comparison program, MyExpertQC. Diagnostica Stago’s suite of digital services, including remote monitoring and proactive instrument alerts, further enhance the value of STA Coag Expert by reducing TAT and increasing system efficiency.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.